Growth Metrics

Veracyte (VCYT) Non-Current Deferred Tax Liability: 2014-2025

Historic Non-Current Deferred Tax Liability for Veracyte (VCYT) over the last 6 years, with Sep 2025 value amounting to $1.2 million.

  • Veracyte's Non-Current Deferred Tax Liability fell 17.41% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 17.41%. This contributed to the annual value of $1.2 million for FY2024, which is 94.81% down from last year.
  • Latest data reveals that Veracyte reported Non-Current Deferred Tax Liability of $1.2 million as of Q3 2025, which was down 6.69% from $1.3 million recorded in Q2 2025.
  • Veracyte's Non-Current Deferred Tax Liability's 5-year high stood at $42.9 million during Q4 2021, with a 5-year trough of $750,000 in Q1 2021.
  • In the last 3 years, Veracyte's Non-Current Deferred Tax Liability had a median value of $1.5 million in 2024 and averaged $4.2 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first spiked by 815.10% in 2021, then crashed by 94.81% in 2024.
  • Veracyte's Non-Current Deferred Tax Liability (Quarterly) stood at $42.9 million in 2021, then declined by 14.25% to $36.7 million in 2022, then crashed by 35.65% to $23.6 million in 2023, then crashed by 94.81% to $1.2 million in 2024, then fell by 17.41% to $1.2 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $1.2 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.2 million for Q1 2025.